Cough Syrup Market Size, Share, Demand, Companies And Research Report By IMARC Group


(MENAFN- IMARC Group) The global cough syrup market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2028, exhibiting a growth rate (CAGR) of 4.11% during 2023-2028.

Market Insight:

Cough syrup is a combination drug that offers temporary relief from common cold, cough, hay fever, and other respiratory allergies. It is produced using expectorants, non-opioid cough suppressants, and antihistamine compounds to block the symptoms. The suppressants help alleviate the symptoms of dry cough by reducing the activity of the cough reflex and minimizing the urge to cough. The function of the expectorants is to treat a cough with mucus by loosening it, which makes it easy to expel from the body. The antihistamines relieve the cough caused by minor throat or airway irritation. In recent years, cough syrups have gained traction as they are prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in different flavors, such as honey, bubblegum, cherry, and orange.

Request to Get the Sample Report: https://www.imarcgroup.com/cough-syrup-market/requestsample

Market Trends:

One of the primary factors driving the market is the increasing incidences of upper respiratory tract infection (URTI), along with other respiratory disorders globally. Additionally, the rising geriatric population, which is more prone to such diseases, is positively influencing market growth. Other than this, cough syrups are mainly used to treat dry cough, which develops due to prolonged exposure to tobacco, poor air quality, and indoor smoke and air pollution.

Besides this, the growing health consciousness, along with the easy accessibility of this product in pharmacies and general stores, is creating a positive market outlook. In line with this, numerous product innovations, such as the development of cough syrups with minimal effects, are propelling market growth. Other growth-inducing factors include exponential growth in the pharmaceutical industry and expanding disposable income levels.

Cough Syrup Companies Covered:

  • Acella Pharmaceuticals LLC
  • Bayer AG, GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company

Explore Full Report Description At: https://www.imarcgroup.com/cough-syrup-market

Report Segmentation:

The report has segmented the global cough syrup market on the basis of product type, age group, distribution channel and region.

Breakup by Product Type:

  • Expectorants
  • Cough Suppressants/Antitussives
  • Combination Medications

Breakup by Age Group:

  • Pediatric
  • Adult

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Ask An Analyst:: https://www.imarcgroup.com/request?type=report&id=3917&flag=C

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

MENAFN27022024004122016232ID1107904988


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.